Citation of this article
Corresponding Author of This Article
Article-Type of This Article
Open-Access Policy of This Article
Times Cited Counts in Google of This Article
Number of Hits and Downloads for This Article
- Total Article Views (2717)
All Articles published online
|
Jan 7, 2006 (publication date) through Apr 24, 2024
Times Cited of This Article
Journal Information of This Article
Publication Name
World Journal of Gastroenterology
ISSN
1007-9327
Publisher of This Article
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
| For: | Guo Q, Tang W, Inagaki Y, Midorikawa Y, Kokudo N, Sugawara Y, Nakata M, Konishi T, Nagawa H, Makuuchi M. Clinical significance of subcellular localization of KL-6 mucin in primary colorectal adenocarcinoma and metastatic tissues. World J Gastroenterol 2006; 12(1): 54-59 [PMID: 16440417 DOI: 10.3748/wjg.v12.i1.54] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v12/i1/54.htm |
| Number | Citing Articles |
| 1 |
Takahiko Matsushita, Naoki Ohyabu, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Hiroshi Hinou, Shin-Ichiro Nishimura. Site-Specific Conformational Alteration Induced by Sialylation of MUC1 Tandem Repeating Glycopeptides at an Epitope Region for the Anti-KL-6 Monoclonal Antibody. Biochemistry 2013; 52(2): 402 doi: 10.1021/bi3013142
|
| 2 |
Huan-Li Xu, Xin Zhao, Ke-Ming Zhang, Wei Tang, Norihiro Kokudo. Inhibition of KL-6/MUC1 glycosylation limits aggressive progression of pancreatic cancer. World Journal of Gastroenterology 2014; 20(34): 12171-12181 doi: 10.3748/wjg.v20.i34.12171
|
| 3 |
Sabine Heublein, Doris Mayr, Markus Egger, Uwe Karsten, Steffen Goletz, Martin Angele, Julia Gallwas, Udo Jeschke, Nina Ditsch. Immunoreactivity of the fully humanized therapeutic antibody PankoMab-GEX™ is an independent prognostic marker for breast cancer patients. Journal of Experimental & Clinical Cancer Research 2015; 34(1) doi: 10.1186/s13046-015-0152-7
|
| 4 |
Ryukou Izumi, Takahiko Matsushita, Naoki Fujitani, Kentaro Naruchi, Hiroki Shimizu, Sakae Tsuda, Hiroshi Hinou, Shin‐Ichiro Nishimura. Microwave‐Assisted Solid‐Phase Synthesis of Antifreeze Glycopeptides. Chemistry – A European Journal 2013; 19(12): 3913 doi: 10.1002/chem.201203731
|
| 5 |
Shobith Rangappa, Gerard Artigas, Risho Miyoshi, Yasuhiro Yokoi, Shun Hayakawa, Fayna Garcia-Martin, Hiroshi Hinou, Shin-Ichiro Nishimura. Effects of the multiple O-glycosylation states on antibody recognition of the immunodominant motif in MUC1 extracellular tandem repeats. MedChemComm 2016; 7(6): 1102 doi: 10.1039/C6MD00100A
|
| 6 |
Megumi Kiyoi, Tatsuya Yoshimasu, Fuminori Ota, Koma Naito, Yoshimitsu Hirai, Yoshitaka Okamura. Two cases of rectal cancer metastasizing to the lung with a high serum KL-6 level. The Journal of the Japanese Associtation for Chest Surgery 2008; 22(6): 933 doi: 10.2995/jacsurg.22.933
|
| 7 |
Sonosuke Tanaka, Noboru Hattori, Nobuhisa Ishikawa, Hiroyasu Shoda, Atsushi Takano, Ryohei Nishino, Morihito Okada, Koji Arihiro, Kouki Inai, Hironobu Hamada, Akihito Yokoyama, Nobuoki Kohno. Krebs von den Lungen‐6 (KL‐6) is a prognostic biomarker in patients with surgically resected nonsmall cell lung cancer. International Journal of Cancer 2012; 130(2): 377 doi: 10.1002/ijc.26007
|
| 8 |
K. Veluraja, K.N. Vennila, K. Umamakeshvari, A. Jasmine, D. Velmurugan. Structural investigation of porcine stomach mucin by X-ray fiber diffraction and homology modeling. Biochemical and Biophysical Research Communications 2011; 406(4): 570 doi: 10.1016/j.bbrc.2011.02.092
|
| 9 |
Yoshinori Inagaki, Yasuji Seyama, Kiyoshi Hasegawa, Wei Tang, Norihiro Kokudo. Subcellular localization of KL-6 mucin in intraductal papillary mucinous neoplasm of the pancreas. Drug Discoveries & Therapeutics 2014; 8(4): 173 doi: 10.5582/ddt.2014.01027
|
| 10 |
H.L. Xu, Y. Inagaki, Y. Seyama, Y. Sugawara, N. Kokudo, M. Nakata, F.S. Wang, W. Tang. Expression of KL-6 mucin, a human MUC1 mucin, in intrahepatic cholangiocarcinoma and its potential involvement in tumor cell adhesion and invasion. Life Sciences 2009; 85(9-10): 395 doi: 10.1016/j.lfs.2009.07.004
|
| 11 |
Naoe Yanagisawa, Naohiko Koide, Harunari Fukai, Yoshinori Koyama, Yuu Ogihara, Maki Ohya. Two cases of gastric cancer with elevated serum levels of KL-6. Surgical Case Reports 2024; 10(1) doi: 10.1186/s40792-024-01883-0
|
| 12 |
Hiroyuki Tsuchie, Seiya Miyamoto, Yoichi Kataoka, Seietsu Senma, Yuichiro Narita, Yuji Hatakeyama, Moto Kobayashi, Kana Sasaki, Yoichi Shimada. Rheumatoid Arthritis with High Serum KL-6 Complicating Malignant Tumor: Two Case Reports. Open Journal of Orthopedics 2015; 5(03): 41 doi: 10.4236/ojo.2015.53006
|
| 13 |
Chao Li, Tao Liu, Libin Yin, Didi Zuo, Yuyang Lin, Lei Wang. Prognostic and clinicopathological value of MUC1 expression in colorectal cancer. Medicine 2019; 98(9): e14659 doi: 10.1097/MD.0000000000014659
|
| 14 |
Naoki Ohyabu, Hiroshi Hinou, Takahiko Matsushita, Ryukou Izumi, Hiroki Shimizu, Keiko Kawamoto, Yoshito Numata, Hiroko Togame, Hiroshi Takemoto, Hirosato Kondo, Shin-Ichiro Nishimura. An Essential Epitope of Anti-MUC1 Monoclonal Antibody KL-6 Revealed by Focused Glycopeptide Library. Journal of the American Chemical Society 2009; 131(47): 17102 doi: 10.1021/ja903361f
|
| 15 |
Tae Mogami, Haruya Saji, Naho Yokota, Rie Suzuki, Akiko Sukegawa, Mikiko Asai-Sato, Etsuko Miyagi, Fumiki Hirahara. Serum KL-6 for diagnosis of ovarian carcinoma associated with dermatomyositis: two case reports and characteristic clinicopathological factors. International Cancer Conference Journal 2012; 1(2): 83 doi: 10.1007/s13691-012-0016-3
|
| 16 |
Teresa M. Horm, Joyce A. Schroeder. MUC1 and metastatic cancer. Cell Adhesion & Migration 2013; 7(2): 187 doi: 10.4161/cam.23131
|
| 17 |
Subhankar Chakraborty, Maneesh Jain, Aaron R Sasson, Surinder K Batra. MUC4 as a diagnostic marker in cancer. Expert Opinion on Medical Diagnostics 2008; 2(8): 891 doi: 10.1517/17530059.2.8.891
|
| 18 |
Huanli Xu, Yoshinori Inagaki, Yasuji Seyama, Kiyoshi Hasegawa, Yasuhiko Sugawara, Guanhua Du, Fengshan Wang, Wei Tang, Norihiro Kokudo. Expression of KL-6/MUC1 in pancreatic ductal carcinoma and its potential relationship with β-catenin in tumor progression. Life Sciences 2011; 88(23-24): 1063 doi: 10.1016/j.lfs.2011.03.021
|
| 19 |
A. Seko, T. Ohkura, H. Ideo, K. Yamashita. Novel O-linked glycans containing 6'-sulfo-Gal/GalNAc of MUC1 secreted from human breast cancer YMB-S cells: Possible carbohydrate epitopes of KL-6(MUC1) monoclonal antibody. Glycobiology 2012; 22(2): 181 doi: 10.1093/glycob/cwr118
|
| 20 |
Yunhui Zeng, Qiongwen Zhang, Yujie Zhang, Minxun Lu, Yang Liu, Tianying Zheng, Shijian Feng, Meiqin Hao, Huashan Shi, Pankaj K Singh. MUC1 Predicts Colorectal Cancer Metastasis: A Systematic Review and Meta-Analysis of Case Controlled Studies. PLOS ONE 2015; 10(9): e0138049 doi: 10.1371/journal.pone.0138049
|
| 21 |
Yaron Niv, Theodore Rokkas. Mucin Expression in Colorectal Cancer (CRC). Journal of Clinical Gastroenterology 2019; 53(6): 434 doi: 10.1097/MCG.0000000000001050
|
| 22 |
Yasuni Nakanuma, Tsuneyuki Uchida, Yasunori Sato, Katsuhiko Uesaka. An S100P-positive biliary epithelial field is a preinvasive intraepithelial neoplasm in nodular-sclerosing cholangiocarcinoma. Human Pathology 2017; 60: 46 doi: 10.1016/j.humpath.2016.10.003
|